REQUEST A DEMO
Total
USD $0.00
Search more companies

Fluart Innovative Vaccines Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Hospitals | Outpatient Care Centers | General Medical and Surgical Hospitals
Full name: Fluart Innovative Vaccines Kft. Profile Updated: August 31, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Hungarian Download a sample report

The Fluart Innovative Vaccines Kft. (formerly. Omninvest Kft.), is a Hungarian pharmaceutical company,headquartered in Pilisborosjeno. For more than two decades is a key player in the Hungarian public health strategy of defense against influenza. The company has been incorporated in 1992. The company operates in the following areas: production of vaccines against flu, pharmaceutical products, research, development, production and trading.

Headquarters
Fo u. 7.
Pilisborosjeno; Pest; Postal Code: 2097

Contact Details: Purchase the Fluart Innovative Vaccines Kft. report to view the information.

Website: http://www.omninvest.hu

Basic Information
Total Employees:
Purchase the Fluart Innovative Vaccines Kft. report to view the information.
Outstanding Shares:
Purchase the Fluart Innovative Vaccines Kft. report to view the information.
Registered Capital:
Purchase the Fluart Innovative Vaccines Kft. report to view the information.
Financial Auditors:
Purchase the Fluart Innovative Vaccines Kft. report to view the information.
Incorporation Date:
December 11, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Fluart Development Kft.
Omninvest Asia Befektetesi Kft. v.a.
UD Pilot Therapy Kutatasfejleszto, Gyarto es Kereskedelmi Kft.
Company Performance
Financial values in the chart are available after Fluart Innovative Vaccines Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
40.47%
Total operating revenue
41.79%
Operating profit (EBIT)
-36.43%
EBITDA
-3.02%
Net Profit (Loss) for the Period
-58.72%
Total assets
1.89%
Total equity
1.45%
Operating Profit Margin (ROS)
-3.37%
Net Profit Margin
-3.8%
Return on Equity (ROE)
-3.17%
Quick Ratio
0.45%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?